CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project.
about
Topiramate in the new generation of drugs: efficacy in the treatment of alcoholic patients.Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and managementProteomic approaches and identification of novel therapeutic targets for alcoholismDiagnosis of alcoholic liver disease.Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.Naltrexone long-acting formulation in the treatment of alcohol dependence.Patient-centered primary care for adults at high risk for AUDs: the Choosing Healthier Drinking Options In primary CarE (CHOICE) trial.Apo-AII is an elevated biomarker of chronic non-human primate ethanol self-administration.Diagnostic values of surface-enhanced laser desorption/ionization technology for screening of habitual drinkers.Effects of hepatic drug-metabolizing enzyme induction on clinical pathology parameters in animals and man.Elevated serum gamma-glutamyltransferase is associated with an increased risk of oesophageal carcinoma in a cohort of 8,388,256 Korean subjects.Estimating driver risk using alcohol biomarkers, interlock blood alcohol concentration tests and psychometric assessments: initial descriptives.How accurate are blood (or breath) tests for identifying self-reported heavy drinking among people with alcohol dependence?Circulating cytokines as biomarkers of alcohol abuse and alcoholismClassification of alcohol abuse by plasma protein biomarkersFuture prospects for biomarkers of alcohol consumption and alcohol-induced disordersMotivational interviewing with primary care populations: a systematic review and meta-analysis.Diagnostic performance of ethyl glucuronide in hair for the investigation of alcohol drinking behavior: a comparison with traditional biomarkers.Heavy alcohol use in lung donors increases the risk for primary graft dysfunctionThe effect of malnutrition on protein glycosylation in childrenThe correlates of urinary albumin to creatinine ratio (ACR) in a high risk Australian aboriginal community.Plasma proteomic alterations in non-human primates and humans after chronic alcohol self-administration.Validation of the Bayesian Alcoholism Test compared to single biomarkers in detecting harmful drinking.Operating characteristics of carbohydrate-deficient transferrin (CDT) for identifying unhealthy alcohol use in adults with HIV infectionTraditional markers of excessive alcohol use.Current status of carbohydrate deficient transferrin, total serum sialic acid, sialic acid index of apolipoprotein J and serum beta-hexosaminidase as markers for alcohol consumption.Use of biomarkers for alcohol use disorders in clinical practice.Efficacy of brief interventions for hazardous drinkers in primary care: systematic review and meta-analyses.Carbohydrate-deficient transferrin (CDT)--a biomarker for long-term alcohol consumption.A review of genetic, biological, pharmacological, and clinical factors that affect carbohydrate-deficient transferrin levels.Emerging biomarkers: new directions and clinical applications.Rhesus monkey model of liver disease reflecting clinical disease progression and hepatic gene expression analysis.The biometric measurement of alcohol consumption.Phosphatidylethanol in blood as a marker of chronic alcohol use: a systematic review and meta-analysis.Liver aminotransferases are elevated with rhabdomyolysis in the absence of significant liver injuryLiver Transplantation for Alcohol-Related Liver DiseaseEthylglucuronide as a biomarker for ethanol detection.KASL clinical practice guidelines: management of alcoholic liver diseaseA proteomic workflow for discovery of serum carrier protein-bound biomarker candidates of alcohol abuse using LC-MS/MSLong-term survival after liver transplantation for alcoholic liver disease.
P2860
Q24632593-B4F14E73-36E3-4FE0-A007-9DCCAF395CBCQ24649618-ADFCF872-5FB1-446A-9A26-40DA4A0CF735Q27023085-B0C4B192-06F3-4319-8E0B-1D60D1616355Q30431186-C35667C8-1EC4-40C0-9C26-5B7D7059ED49Q30440516-ABA045EA-A4C1-4582-9004-5B644E8C8106Q30441807-8851CF58-E014-4A85-A00F-4B79AAA6BB05Q30851487-E43C2C98-1FDA-48B8-AAA6-36FF17C5E0E3Q33238373-21A87455-3497-4EC9-A483-5564234B06F8Q33276236-102B52F9-36C4-4E5E-96F9-F52E772BEA8FQ33618803-6F8D12C8-2E22-4046-83FE-878D8C097AC3Q33643177-617A5BF9-5C98-4226-AF69-DB9705B94D1FQ33671773-01EBA3F9-675B-43D3-9C78-DB70DC23AF29Q33767799-C482C5EF-F18D-43CF-AF14-A9EF989C8C66Q33821192-68964635-CF70-47C1-B81B-FCC9082484A5Q33932437-0563B041-359B-4F68-9A87-1020624BA5F2Q33976216-0843A0BC-3B2C-49D3-AD39-8BBEA1B1AED7Q33988006-89C4138F-9AFD-4F1F-9BC3-A795B217A956Q34215509-0887B274-DE5C-4933-902F-EC726B33A0A4Q34678921-90D97733-95A3-46A7-9CF6-8BF35ECB8A8AQ34772834-8D2D4B56-E845-41B3-8981-2E6A22BF562FQ34943447-D7BAAEC6-6E91-4C2A-A253-0DA3D61A1F6BQ35024002-1DF8A26F-A09B-4BBB-B546-7F389337CA1DQ35067210-8F972A11-352D-4F17-8BEA-8C095E29098AQ35353517-D765FFAC-F108-49D7-BECF-072CF63C349DQ35675680-35DE150B-8D5A-4A23-8885-708E8CD7CE1FQ35675682-2915508B-3408-441A-830C-6BBF9D4EA39DQ35675693-0ED83E71-8229-49DE-A7E8-747F5CBBF81BQ35752357-E814880C-463E-4A88-8D87-9B3F7156D2AFQ35809820-2D2226AE-7C05-486B-94B4-3AAE0CA6957BQ35886418-5E07741B-5083-4462-9AEC-82D904D0179EQ36071949-8CFDF221-8C2B-4C11-8952-930C770C7EFEQ36128791-6CEB174A-AC4D-4E21-A2FF-F97C094C2137Q36288415-CD9F18D3-9CF0-459B-B9A2-1321B67ABFE4Q36432550-07B20745-8614-4689-BB98-BE400A901427Q36549640-FAE2EF24-B2E8-4B25-9E4D-0BF590E7FB62Q36886533-F7D19323-C161-49AD-ACCB-935D9A6406BDQ37173203-FCDA8C4F-4BF7-411D-953B-2A6B97542851Q37229858-93B0EBB7-9A1B-43A3-B940-82F116B5B68AQ37374485-D444CB3D-C87A-4DF1-8F51-7F1773FC6A4AQ37439878-95DEE9AF-3E83-4BAD-97EA-8E3C229B8E91
P2860
CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project.
@en
CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project.
@nl
type
label
CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project.
@en
CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project.
@nl
prefLabel
CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project.
@en
CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project.
@nl
P2093
P2860
P921
P1476
CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project.
@en
P2093
Boris Tabakoff
John B Saunders
John B Whitfield
Katherine M Conigrave
WHO/ISBRA Study Group
P2860
P304
P356
10.1111/J.1530-0277.2002.TB02542.X
P407
P577
2002-03-01T00:00:00Z